Medical HIGH

Mississippi

Mississippi operates a robust, rapidly growing medical cannabis program, having generated $9.00 million in retail sales tax in Calendar Year (CY) 2025, supported by an active patient base of 66,041 individuals.
The state's path to legalization was marked by unprecedented legal turbulence; voters overwhelmingly approved a constitutional medical cannabis initiative (Initiative 65) in 2020, which the Mississippi Supreme Court subsequently invalidated on a procedural technicality, forcing the legislature to pass the Mississippi Medical Cannabis Act (SB 2095) in 2022.
The state faces a volatile regulatory environment regarding hemp-derived cannabinoids, heavily influenced by a sweeping 2025 advisory opinion from Attorney General Lynn Fitch that functionally classifies non-FDA approved intoxicating hemp products as Schedule I controlled substances.
Despite operating a medical cannabis framework, Mississippi maintains aggressive enforcement protocols against the illicit market, marked by persistent racial disparities where Black residents are arrested for cannabis possession at 2.7 times the rate of white residents.

Mississippi presents a highly complex and academically significant case study in Southern cannabis policy. The state represents a unique convergence of strong populist support for medical cannabis access and deeply conservative institutional governance. Research suggests that while the patient registry and associated retail ecosystem are maturing at an impressive rate—adding approximately 50 new patient IDs per day—the regulatory landscape remains fraught with legislative friction. The state operates without an adult-use program, and possession of cannabis outside the strict parameters of the medical program carries escalating penalties that swiftly reach felony status. Furthermore, recent enforcement directives targeting synthetic and hemp-derived cannabinoids highlight an ongoing philosophical conflict within state leadership regarding the boundaries of acceptable cannabis-related commerce.

Medical

Medical Program

Medical Status: Legal — Mississippi Medical Cannabis Act (SB 2095), passed February 2, 2022. First sales commenced January 25, 2023.^[13]
Medical Sales: $97M (2024 estimate); ~$128.5M (CY 2025 extrapolated)^[14]
Dispensaries: 171 actively licensed operational dispensaries^[20]

Mississippi's medical cannabis market has demonstrated robust, compounding growth since first sales in January 2023. The state generated $9.00 million in retail sales tax and $2.18 million in cultivation excise tax in CY 2025, with gross retail sales estimated at approximately $128.5 million for the year — a roughly 30% increase over 2024's estimated $97 million. The state maintained 171 actively licensed dispensaries and 387 total active licenses as of late 2024, including a hyper-proliferation of cultivation capacity (123 cultivation licenses) that has created structural oversupply and compressed wholesale flower prices to $10–$15 per gram. Industry projections suggest cumulative market revenues will reach $300 million by end of 2026. The state also maintained 5,862 active industry work permits by close of CY 2025, up from 4,661 in CY 2024. Total state agency program fees and licensing revenues for 2024 approached $8.97 million, while program administration costs were $6.72 million (MSDOH) plus only $51,228 (MDOR), rendering the program a net-positive fiscal asset.

Penalties (Outside Medical Program)

Offense	Amount	Classification	Penalty
Possession — Flower	Under 30g (first offense)	Misdemeanor	Fine $100–$250; no incarceration if valid ID and written court pledge provided ^[10]
Possession — Flower	Under 30g (subsequent offense)	Misdemeanor	5–60 days jail ^[10]
Possession — Flower	30g–250g	Felony	1–3 years imprisonment; fine up to $3,000 ^[15]
Possession — Flower	250g–500g	Felony	2–8 years imprisonment; fine up to $50,000 ^[15]
Possession — Flower	500g–1kg	Felony	4–16 years imprisonment; fine up to $250,000 ^[15]
Possession — Flower	Over 5kg	Severe Felony	10–30 years imprisonment; fine up to $1,000,000 ^[15]
Possession — Hash/Concentrates	Over 0.1g	Felony	Felony ^[10]
Possession — Hash/Concentrates	2g–10g	Felony	Up to 8 years imprisonment ^[10]
Trafficking — Concentrates	Any amount	Severe Felony	Mandatory 30-year sentence in state penitentiary ^[15]

Criminal Justice

Group	Metric	Value
Black	Disparity Ratio vs. White residents	2.7x more likely to be arrested for cannabis possession than white counterparts, despite similar usage rates ^[27]

Cannabis enforcement in Mississippi is characterized by profound and persistent racial inequality. According to FBI NIBRS data, Mississippi reported 3,758 arrests for cannabis possession in 2023, constituting 49.12% of all drug possession arrests in the state (7,650 total). An additional 200 arrests were made for sale and manufacturing of cannabis. ACLU analysis indicates Black Mississippians are 2.7 times more likely to be arrested for cannabis possession than white counterparts, despite virtually identical usage rates. Post-conviction relief is highly restrictive: only first- and second-time misdemeanor possession convictions are eligible for expungement after two years, and no state-initiated automated expungement mechanism exists. Legislative attempts to broaden relief (HB 922 in 2022, SB 2266 in 2023) died in committee.

What Mississippi Is Leaving on the Table

If Mississippi had adult-use cannabis sales at the level of operational states:

Benchmark	Per Capita	Rank	Estimated MS Market
Connecticut (#20)	$60.73	Lowest	$179M
New Jersey (#15)	$126.23	Mid-pack	$373M
Colorado (#9)	$196.26	Mature	$580M

Based on total state population and per capita sales from operational markets. Actual results vary by market design, tax structure, licensing speed, and border dynamics. See how all 20 legal states compare →

Borders

Border Dynamics

Neighbor	Legal Status	Notes
Arkansas	Medical only	Cross-border purchasing dynamics not published in available sources
Louisiana	Medical only	Cross-border purchasing dynamics not published in available sources
Tennessee	Prohibited (decriminalized in some jurisdictions)	Cross-border purchasing dynamics not published in available sources
Alabama	Medical only	Cross-border purchasing dynamics not published in available sources

Data concerning cross-border purchasing patterns between Mississippi and its border states (Arkansas, Louisiana, Alabama, Tennessee) was not published in available sources. All four neighboring states operate medical-only or prohibited frameworks, limiting outbound purchasing pressure.

Economic

Economic Opportunity

Fiscal Note: CY 2025: $11.18M in direct cannabis tax revenue ($9.00M retail + $2.18M excise). Program administration costs: $6.72M (MSDOH) + $51,228 (MDOR). Net-positive fiscal asset for state government. Total state agency program fees and licensing revenues for 2024 approached $8.97M.^[20]
Jobs Estimate: 5,862 active industry work permits as of close of CY 2025 (up from 4,661 in CY 2024). Specific FTE employment aggregation not published.^[20]

Mississippi's medical cannabis sector has expanded rapidly. Gross retail sales are estimated at approximately $128.5 million for CY 2025 (extrapolated from $9.00M retail tax at 7% rate), up roughly 30% from 2024's estimated $97 million. Industry analysts project cumulative lifetime market revenues of $300 million by end of 2026. The program generated $11.18 million in direct tax revenue in CY 2025 against program administration costs of approximately $6.77 million, making it a net-positive fiscal asset. Active industry work permits surged from 4,661 (CY 2024) to 5,862 (CY 2025), serving as a proxy for workforce growth.

Political

Political Trajectory

Active Bills: 2026 session: HB 895 (passed House 98-11) — extends medical cannabis ID validity from one to two years and removes THC caps on tinctures/concentrates. HB 1152 (passed House 84-11) — empowers State Health Officer to approve patients without a specifically codified qualifying condition if conventional treatments have failed. HB 1034 'Ryan's Law' (passed House 117-1) — guarantees access to medical cannabis for terminally ill patients in hospital care settings.^[11]
Polling Support: 63% of voters wanted the legislature to pass legislation identical to original Initiative 65. 52% of Mississippians support full legalization of adult-use recreational cannabis. Despite majority public support, the Republican-controlled legislature is highly unlikely to entertain adult-use legalization in the near term.^[35]
Ballot Initiative: The Mississippi Supreme Court's May 2021 ruling in In Re: Initiative Measure No. 65 effectively destroyed the state's citizen ballot initiative process, making future citizen-led cannabis initiatives constitutionally impossible without legislative action to restore the initiative process.^[19]

Mississippi presents a stark ideological disconnect between the voting populace and elected officials. Voters approved Initiative 65 at 74% in 2020, only to have it voided by the Supreme Court. Millsaps College polling shows 52% of Mississippians now support full adult-use legalization, yet the Republican-controlled legislature prioritizes incremental medical optimizations. The 2026 session produced meaningful patient-access improvements — ID renewal extension, removal of THC caps, expanded qualifying conditions — but adult-use legalization remains politically unreachable in the near term. Special elections in November 2025 broke the Republican Senate supermajority (reducing it to 34R/18D), a development that could marginally improve reform prospects but is unlikely to shift the fundamental dynamic.